Mode of Action: Angiotensin-Converting Enzyme Inhibition—Developmental Effects Associated With Exposure to ACE Inhibitors

REFERENCES

• Assali N. S., Holm L. W., Sehgal N. Regional blood flow and vascular resistance of the fetus in utero. Action of vasoactive drugs. Am. J. Obstet. Gynecol. 1962; 5: 809–817, [CSA]
   Google Scholar
• Barr M., Jr. Teratogen update: Angiotensin-converting enzyme inhibitors. Teratology 1994; 50: 399–409, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Barr M., Jr. Angiotensin-converting enzyme inhibitor fetopathy. Handbook of Experimental Pharmacology: Drug Toxicity in Embryonic Development II, R. J. Kavlock G. P. Daston. Springer-Verlag, New York 1997; 265–294
   Google Scholar
• Barr M., Jr., Cohen M. M., Jr. ACE inhibitor fetopathy and hypocalvaria: The kidney–skull connection. Teratology 1991; 44: 485–495, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Beguin F., Dunnihoo D. R., Quilligan E. J. Effect of carbon dioxide elevation on renal blood flow in the fetal lamb in utero. Am. J. Obstet. Gynecol. 1974; 119: 630–637, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Bhatt-Mehta V., Deluga K. S. Fetal exposure to lisinopril: Neonatal manifestations and management. Pharmacotherapy 1993; 13: 515–518, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Binder N. D., Anderson D. F. Plasma renin activity responses to graded decreases in renal perfusion pressure in fetal and newborn lambs. Am. J. Physiol. 1992; 262: R254–R259, [CSA]
   Google Scholar
• Brent R. L., Beckman D. A. Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: Information for clinical teratology counselors. Teratology 1991; 43: 543–546, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Broughton-Pipkin F., Wallace C. P. The effect of enalapril (MK-421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her fetus. Br. J. Pharmacol. 1986; 87: 533–542, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Broughton-Pipkin F., Baker P. N., Symonds E. M. ACE inhibitors in pregnancy. Lancet 1989; 2: 96–97, Letter[CSA]
   PubMedGoogle Scholar
• Broughton-Pipkin F., Symonds E. M., Turner S. R. The effect of captopril (SQ14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. J. Physiol. 1982; 323: 415–422, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Buttar H. S. An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol. Cell. Biochem. 1997; 176: 61–71, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cunniff C., Jones K. L., Benirschke K., Short S., Wujek J. Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril. Am. J. Obstet. Gynecol. 1990; 162: 187–189, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Davidson D., Stalcup S. A., Mellins R. B. Angiotensin-converting enzyme activity and its modulation by oxygen tension in the guinea pig fetal-placental unit. Circ. Res. 1981; 48: 286–291, [CSA]
   PubMedGoogle Scholar
• Dostal L. A., Kim S. N., Schardein J. L., Anderson J. A. Fertility and perinatal/postnatal studies in rats with the angiotensin-converting enzyme inhibitor, quinapril. Fundam. Appl. Toxicol. 1991; 17: 684–695, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Ducsay C. A., Cook M. J., Veille J. C., Novy M. J. Cardiorespiratory effects of calcium channel-blocker tocolysis in pregnant rhesus monkeys. The Physiological Development of the Fetus and Newborn, C. T. Jones, P. W. Natanielsz. Academic Press, London 1985; 423–428
   Google Scholar
• Ducsay C. A., Thompson J. S., Wu A. T., Novy M. J. Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques: Fetal plasma concentrations and cardiorespiratory changes. Am. J. Obstet. Gynecol. 1987; 157: 1482–1486, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Ducsay C. A., Umezaki H., Kaushal K., Barrish A., Gilbert J., Manson J. Pharmacokinetic and fetal cardiovascular effects of enalaprilat administration to maternal rhesus macaque. Am. J. Obstet. Gynecol. 1996; 175: 50–55, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Endo M., Yamada Y., Kohno M., Suzuki T., Otsuka M., Takaiti O. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 4th communication: Placental transfer and secretion into milk in rats. Arzneimittelforschung 1992; 42: 483–489, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Ferris T. F., Weir E. K. Effect of captopril on uterine blood flow and prostaglandin E synthesis in the pregnant rabbit. J. Clin. Invest. 1983; 71: 809–815, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ferris T. F., Stein J. H., Kauffman J. Uterine blood flow and uterine renin secretion. J. Clin. Invest. 1972; 51: 2827–2833, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Franklin G. O., Dowd A. J., Caldwell B. V., Speroff L. The effect of angiotensin II intravenous infusion of plasma renin activity and prostaglandins A, E, and F levels in the uterine vein of the pregnant monkey. Prostaglandins 1974; 6: 271–280, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Friberg P., Sundelin B., Bohman S. O., Bobik A., Nilsson H., Wickman A., Gustafsson H., Petersen J., Adams M. A. Renin-angiotensin system in neonatal rats: Induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney Int. 1994; 45: 485–492, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gerber J. G., Payne N. A., Murphy R. C., Nies A. S. Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance. J. Clin. Invest. 1981; 67: 632–636, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gomez R., Lunch K., Sturgill B., Elwood J., Chevalier R., Carey R., Peach M. Distribution of renin mRNA and its protein in the developing kidney. Am. J. Physiol. 1989; 257(5 Pt 2)F850–F858, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Gross D. M., Sweet C. S., Ulm E. H., Backlund E. P., Morris A. A., Weitz D., Bohn D. L., Wenger H. C., Vassil T. C., Stone C. A. Effect of N-[(s)-1-carboxyl-3-phenylpropyl]- L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin pressor responses in vivo. J. Pharmacol. Exp. Ther. 1981; 216: 552–557, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Guignard J. P., Goyon J. B. Adverse effects of drugs on the immature kidney. Biol. Neonate 1988; 53: 243–252, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hall J. E., Guyton A. C., Trippodo N. C., Lohmeier T. E., McCaa R. E., Cowley A. W., Jr. Intrarenal control of electrolyte excretion by angiotensin II. Am. J. Physiol. 1977a; 232: F538–F544, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hall J. E., Guyton A. C., Jackson T. E., Coleman T. G., Lohmeier T. E., Trippodo N. C. Control of glomerular filtration rate by the renin–angiotensin system. Am. J. Physiol. 1977b; 233: F366–F372, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Harewood W. J., Phippard A. F., Duggin G. G., Horvath J. S., Tiller D. J. Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: A prospective, placebo-controlled study in baboons (Papio hamadryas). Am. J. Obstet. Gynecol. 1994; 171: 633–642, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hebert F., Fouron J. C., Boileau J. C., Biron P. Pulmonary fate of vasoactive peptides in fetal, newborn, and adult sheep. Am. J. Physiol. 1972; 223: 20–23, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Hoppe B., Neuhaus T., Weisser B., Leumann E. Clinical quiz. What is the cause of anuria in this newborn infant?. Pediat. Nephrol. 1993; 7: 769–770, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Hulton S. A., Thomson P. D., Cooper P. A., Rothberg A. D. ACE inhibitors in pregnancy may result in neonatal renal failure. S. Afr. Med. J. 1990; 78: 673–676, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Ice K. S., Geary K. M., Gomez R. A., Johns D. W., Peach M. J., Carey R. M. Cell and molecular studies of renin secretion. Clin. Exp. Hypertens. A 1988; 10: 1169–1187, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ito T., Woo J., Haning R., Horton R. A radioimmunoassay for aldosterone in human peripheral plasma including a comparison of alternate techniques. J. Clin. Endocrinol. Metab. 1972; 34: 106–112, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jackson E. K., Garrison J. C. Renin and angiotensin. The Pharmacological Basis of Therapeutics, 9th ed., J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, A. G. Gilman. McGraw-Hill, New York 1996; 733–758
   Google Scholar
• Jelinek J., Hackenthal R., Hilgenfeldt U., Schaechtelin G., Hackenthal E. The renin–angiotensin system in the perinatal period in rats. J. Dev. Physiol. 1986; 8: 33–41, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Kreft-Jais C., Plouin P. F., Tchobroutsky C., Boutroy M. J. Angiotensin-converting enzyme inhibitors during pregnancy: A survey of 22 patients given captopril and nine given enalapril. Br. J. Obstet. Gynaecol. 1988; 95: 420–422, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Kubo S. H., Cody R. J. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. Clin. Pharmacokinet. 1985; 10: 377–391, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lau C. S., Kavlock R. J. Functional toxicity in the developing heart, lung, and kidney. Developmental Toxicology 2nd ed., C. A. Kimmel, J. Buelke-Sam. Raven Press, New York 1994; 119–187
   Google Scholar
• Lavoratti G., Seracini D., Fiorini P., Cocchi C., Materassi M., Donzelli G., Pela I. Neonatal anuria by ACE inhibitors during pregnancy. Nephron 1997; 76: 235–236, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Lewis P. J., Boylan P., Friedman L. A., Hensby C. N., Dowling I. Prostacyclin in pregnancy. Br. Med. J. 1980; 280: 1581–1582, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Magee L. A., Conover B., Schick B., Sage S., Cook L., Raman-Williams L., Koren G. Exposure to calcium-channel blockers in human pregnancy. A prospective, controlled, multicentre cohort study. Teratology 1994; 49: 372, abstr.[CSA]
   Google Scholar
• Martin R., Jones K., Mendoza A., Barr M., Benirschke K. Effect of ACE inhibition on the fetal kidney: Decreased renal blood flow. Teratology 1992; 46: 317–321, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Mehta N., Modi N. ACE inhibitors in pregnancy. Lancet 1989; 2: 96, letter[CSA], [CROSSREF]
   PubMedGoogle Scholar
• Minsker D. A., Bagdon W. J., MacDonald J. S. Maternotoxicity and fetotoxicity of an angiotensin-converting enzyme inhibitor, enalapril, in rabbits. Fundam. Appl. Toxicol. 1990; 14: 461–470, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Moore K. L., Persaud T. V.N. The developing human. Clinically oriented embryology, 5th ed. W.B. Saunders, Philadelphia 1993
   Google Scholar
• NDA 18-998. Review and evaluation of pharmacology and toxicology data. Redacted for public release by Freedom of Information Office, Food and Drug Administration, Food and Drug Administration, Washington, DC 1983
   Google Scholar
• Patchett A. A., Harris E., Tristram E. W., Wyvratt M. J., Wu M. T., Taub D., Peterson E. R., Iketer T. J., ten Broeke J., Payne L. G., Ondeyka D. L., Thorsett E. D., Greenlee W. J., Lohr N. S., Hoffsommer R. D., Joshua H., Ruyle W. V., Rothrock J. W., Aster S. D., Maycock A. L., Robinson F. M., Hirschmann R., Sweet C. S., Ulm E. H., Gross D. M., Vassil T. C., Stone C. A. A new class of angiotensin-converting enzyme inhibitors. Nature 1980; 288: 280–283, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Physicians' Desk Reference, 56 edition. Medical Economics Company, Inc., Montvale, NJ 2002, 07645-1742
   Google Scholar
• Piper J. M., Ray W. A., Rosa F. W. Pregnancy outcome following exposure to ACE inhibitors. Obstet. Gynecol. 1992; 80: 429–432, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Poizner A. M., Dowing G. J. Renin-angiotensin system in placenta. Placental Toxicology, B. V. Rama Sastry. CRC Press, Boca Raton, FL 1995; 175–196
   Google Scholar
• Pryde P. G., Sedman A. B., Nugent C. E., Barr M. Angiotensin-converting enzyme inhibitor fetopathy. J. Am. Soc. Nephrol. 1993; 3: 1575–1582, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Reisenberger K., Egarter C., Sternberger B., Eckenberger P., Eberle E., Weissenbacher E. R. Placental passage of angiotensin-converting enzyme inhibitors. Am. J. Obstet. Gynecol. 1996; 174: 1450–1455, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Rhabdour M., Lenoir S., Bouissou F., Rolland M., Fournie A. Effets foetaux et neonatals d'un traitement maternel par inhibiteur de l'enzyme de conversion de l'angiotensine. Arch. Pediatr. 1994; 1: 497–500, [CSA]
   PubMedGoogle Scholar
• Robillard J. E., Gomez R. A., VanOrden D., Smith F. G. Comparison of the adrenal and renal responses to angiotensin II in fetal lambs and adult sheep. Circ. Res. 1982; 50: 140–147, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Robillard J. E., Weissmann D. N., Gomez R. A., Ayres N. A., Layton W. J., Van Orden D. E. Renal and adrenal responses to converting-enzyme inhibition in fetal and newborn life. Am. J. Physiol. 1983; 244: R249–R256, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Rosa F. W., Bosco L. A., Graham C. F., Milstien J. B., Dreis M., Creamer J. Neonatal anuria with maternal angiotensin-converting enzyme inhibition. Obstet. Gynecol. 1989; 74: 371–374, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rothberg A. D., Lorenz R. Can captopril cause fetal and neonatal renal failure?. Pediatr. Pharmacol. 1984; 4: 189–192, [CSA]
   PubMedGoogle Scholar
• Rudolph A. M., Heymann M. A., Teramo K. A., Barrett C. T., Raiha N. C. Studies on the circulation of the previable human fetus. Pediatr. Res. 1971; 5: 452–465, [CSA]
   Google Scholar
• Scanferla F., Coli U., Landini S., Fracasso A., Morachiello P., Righetto F., Genchi R., Bazzato G. Treatment of pregnancy-induced hyper-tension (PIH) with ACE inhibitor enalapril. Clin. Exp. Hypertens. 1987; B6: 45, abstr.[CSA]
   Google Scholar
• Schubiger G., Flury G., Nusberger J. Enalapril for pregnancy-induced hypertension: Acute renal failure in a neonate. Ann. Intern. Med. 1988; 108: 215–216, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Scott A. A., Purohit D. M. Neonatal renal failure: A complication of maternal antihypertensive therapy. Am. J. Obstet. Gynecol. 1989; 160: 1223–1224, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Smith F., Robillard J. Pathophysiology of fetal renal disease. Semin. Perinatol. 1989; 13: 305–319, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Speroff L., Hanwig R. V., Levin R. M. The effect of angiotensin II and indomethacin on uterine artery blood flow in pregnant monkeys. Obstet. Gynecol. 1977; 50: 611–614, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Tabacova S., Little R., Tsong Y., Vega A., Kimmel C. A. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol. Drug Safety 2002; 11: 1–14, [CSA], [CROSSREF]
   Google Scholar
• Thorpe-Beeston J., Armar N. A., Dancy M., Cochrane G. W., Ryan G., Rodeck C. H. Pregnancy and ACE inhibitors. Br. J. Obstet. Gynecol. 1993; 100: 692–693, [CSA]
   PubMedGoogle Scholar
• Tocco D. J., DeLuna F. A., Duncan A. E.W., Vassil T. C., Ulm E. H. The physiological disposition and metabolism of enalapril maleate in laboratory animals. Drug Metab. Dispos. 1982; 10: 15–19, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ulm E. H., Hichens M., Gomez H. J., Till A. E., Hand E., Vassil T. C., Biollaz J., Brunner H. R., Schelling J. L. Enalapril maleate and a lysine analogue (MK-521). Disposition in man. Br. J. Clin. Pharmacol. 1982; 14: 357–362, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Venuto R., O'dorisio T., Stein J. H., Ferris T. F. The effect of prostaglandin inhibition on uterine blood flow. J. Clin. Invest. 1975; 55: 193–197, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wallace K. B., Bailie M. D., Hook J. B. Development of angiotensin-converting enzyme in fetal rat lungs. Am. J. Physiol. 1979; 236: R57–R60, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Weir R. J., Brown J. J., Fraser R., Lever A. F. Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease of pregnancy. Lancet 1973; 1: 291–295, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wigger H. J., Stalcup S. A. Distribution and development of angiotensin converting enzyme in fetal and newborn rabbit. Lab. Invest. 1978; 38: 581–585, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar